Mechanism of Danzhi Jiangtang Capsules in treatment of diabetic macrovascular disease in GK rats based on correlation between microRNAs and inflammatory factors.
10.19540/j.cnki.cjcmm.20190416.401
- Author:
Liang-Zhen YOU
1
;
Dong-Dong YU
2
;
Wan-Qiu HUANG
3
;
Yun-Dong YIN
1
;
Shu YE
4
;
Zhao-Hui FANG
5
Author Information
1. Graduate Institute,Anhui University of Chinese Medicine Hefei 230038,China Institute of Prevention and Treatment of Diabetes,Anhui Academy of Chinese Medicine Hefei 230038,China.
2. Graduate Institute,Anhui University of Chinese Medicine Hefei 230038,China.
3. College of Life Sciences,Anhui University of Chinese Medicine Hefei 230038,China.
4. Graduate Institute,Anhui University of Chinese Medicine Hefei 230038,China College of Life Sciences,Anhui University of Chinese Medicine Hefei 230038,China.
5. Department of Endocrinology,the First Affiliated Hospital of Anhui University of Chinese Medicine Hefei 230038,China Institute of Prevention and Treatment of Diabetes,Anhui Academy of Chinese Medicine Hefei 230038,China.
- Publication Type:Journal Article
- Keywords:
Danzhi Jiangtang Capsules(DJC);
GK rats;
diabetic macrovascular disease;
inflammation;
microRNA
- MeSH:
Animals;
Capsules;
Diabetes Mellitus;
Drugs, Chinese Herbal/therapeutic use*;
MicroRNAs;
Rats;
Rats, Wistar
- From:
China Journal of Chinese Materia Medica
2019;44(20):4519-4528
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to investigate the mechanism of Danzhi Jiangtang Capsules( DJC) in the treatment of diabetic macrovascular disease in Goto-Kakizaki( GK) rats. The diabetic macrovascular disease rat model was induced by feeding high-fat and high-sugar combined with endothelial nitric oxide synthase( NOS) inhibitor N-nitro-L-arginine methyl ester( L-NAME)( 0. 1 g·L-1·d-1). According to the random array table,the model rats were randomly divided into the model group,DJC groups( 1 260,630,320 mg·kg-1),atorvastatin group( 105 mg·kg-1) and metformin group( 10 mg·kg-1),with 12 rats in each group. The rats received gavage administration for 8 weeks. Twelve Wistar rats were selected as the normal control group. The changes of body weight,water intake,blood glucose,plasma total cholesterol( TC),triglyceride( TG),high density lipoprotein( HDL-C),low density lipoprotein( LDL-C),interleukin( IL-1β),IL-6,tumor necrosis factor( TNF-α),nitric oxide( NO),endothelin( ET-1) were observed in these rats. Aortic tissue was taken and the pathological changes were observed by HE staining. RT-PCR was used to detect the mRNA levels of IL-1β,IL-6,and TNF-α in rat aorta. RT-PCR of the stem loop was used to detect the levels of miRNA-126,miRNA-155,miRNA-146 a,and miRNA-21 in rat plasma and aortic tissue. The canonical correlation between miRNAs and inflammatory factors was then analyzed. The results showed that DJC increased the rat body weight,lowered water intake,reduced the random blood glucose,reversed the rat aorta tissue damage,reduced serum TC,TG,LDL-C,ET-1,IL-1β,IL-6,TNF-α,as well as miRNA-155,miRNA-146 a and miRNA-21 levels in serum,elevated plasma HDL-C,NO content,reduced the aorta mRNA of IL-1β,IL-6,TNF-α,and the miRNA-155,miRNA-146 a and miRNA-21,elevated miRNA-126 expression in aorta. Aortic miRNA-126,miRNA-155,miRNA-146 a and miRNA-21 expression levels were typically correlated with the expression of inflammatory factors,among which miRNA-126 was negatively correlated,miRNA-155,miRNA-146 a and miRNA-21 were positively correlated with the factors. These results suggested that DJC had therapeutic effects on diabetic macrovascular diseases,and the mechanism of action may be related to the regulation of miRNA-126,miRNA-155,miRNA-146 a and miRNA-21 levels,as well as the reduction of inflammatory factors and vascular inflammatory response.
